210.9K XNAS Volume
XNAS 04 Apr, 2025 5:30 PM (EDT)
| Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|
| Kevin Chung | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2025 | 15,000 | 15,000 | - | - | Restricted Stock Unit | |
| David A. Green | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2025 | 15,000 | 15,000 | - | - | Restricted Stock Unit | |
| Eric Schlorff | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Nov 2024 | 65,000 | 65,000 | - | - | Restricted Stock Unit | |
| Kevin Chung | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Nov 2024 | 15,000 | 15,000 | - | - | Restricted Stock Unit | |
| Kevin Chung | Chief Medical Officer | Purchase of securities on an exchange or from another person at price $ 1.99 per share. | 15 Nov 2024 | 4,250 | 13,685 | - | 2.0 | 8,458 | Common Stock, par value $0.0001 per share |
| Allan Collins | Director | 13 Nov 2024 | 4,000 | 4,000 | - | - | Restricted Stock Unit | ||
| John Neuman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Nov 2024 | 8,000 | 8,000 | - | - | Restricted Stock Unit | |
| Richard Barnett | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Nov 2024 | 4,000 | 4,000 | - | - | Restricted Stock Unit | |
| Kenneth Van Heel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Nov 2024 | 4,000 | 4,000 | - | - | Restricted Stock Unit | |
| Bernadette N. Vincent | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Nov 2024 | 8,000 | 8,000 | - | - | Restricted Stock Unit | |
| Jennifer A. Baird | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Nov 2024 | 8,000 | 8,000 | - | - | Restricted Stock Unit | |
| Kevin Chung | Chief Medical Officer | Purchase of securities on an exchange or from another person at price $ 4.26 per share. | 30 Sep 2024 | 1,000 | 9,435 | - | 4.3 | 4,258 | Common Stock, par value $0.0001 per share |
| John Neuman | Director | Purchase of securities on an exchange or from another person at price $ 2.04 per share. | 14 Jun 2024 | 10,000 | 40,000 | - | 2.0 | 20,405 | Common Stock, par value $0.0001 per share |
| John Neuman | Director | Purchase of securities on an exchange or from another person at price $ 5.24 per share. | 14 Jun 2024 | 10,000 | 30,000 | - | 5.2 | 52,396 | Common Stock, par value $0.0001 per share |
| John Neuman | Director | Purchase of securities on an exchange or from another person at price $ 4.35 per share. | 14 Jun 2024 | 10,000 | 20,000 | - | 4.4 | 43,521 | Common Stock, par value $0.0001 per share |
| John Neuman | Director | Purchase of securities on an exchange or from another person at price $ 3.69 per share. | 14 Jun 2024 | 10,000 | 10,000 | - | 3.7 | 36,905 | Common Stock, par value $0.0001 per share |
| David A. Green | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Apr 2024 | 8,100 | 10,323 | - | 0 | Common Stock, par value $0.0001 per share | |
| David A. Green | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Apr 2024 | 2,223 | 2,223 | - | 0 | Common Stock, par value $0.0001 per share | |
| David A. Green | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Apr 2024 | 752,500 | 752,500 | - | 0 | Common Stock, par value $0.0001 per share | |
| David A. Green | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Apr 2024 | 18,000 | 18,000 | - | - | Restricted Stock Units | |
| Allan Collins | Director | 12 Apr 2024 | 37,943 | 54,343 | - | 0 | Common Stock, par value $0.0001 per share | ||
| Andres Lobo | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Apr 2024 | 32,322 | 40,300 | - | 0 | Common Stock, par value $0.0001 per share | |
| Richard Barnett | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Apr 2024 | 70,264 | 86,664 | - | 0 | Common Stock, par value $0.0001 per share | |
| Bruce M. Rodgers | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Apr 2024 | 36,537 | 44,515 | - | 0 | Common Stock, par value $0.0001 per share | |
| Richard D. Russell | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Apr 2024 | 32,322 | 60,300 | - | 0 | Common Stock, par value $0.0001 per share | |
| Kenneth Van Heel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Apr 2024 | 43,564 | 159,964 | - | 0 | Common Stock, par value $0.0001 per share | |
| Kevin Chung | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Aug 2023 | 16,930 | 85,055 | - | 0 | Common Stock, par value $0.0001 per share | |
| Caryl Baron | Interim CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Aug 2023 | 2,031 | 97,022 | - | 0 | Common Stock, par value $0.0001 | |
| Eric Schlorff | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Aug 2023 | 21,176 | 703,575 | - | 0 | Common Stock, par value $0.0001 per share | |
| Eric Schlorff | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jun 2023 | 417,386 | 682,399 | - | 0 | Common Stock, par value $0.0001 per share | |
| Caryl Baron | Interim CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.53 per share. | 09 Jun 2023 | 15,070 | 94,991 | - | 0.5 | 7,949 | Common Stock, par value $0.0001 per share |
| Caryl Baron | Interim CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jun 2023 | 56,869 | 110,061 | - | 0 | Common Stock, par value $0.0001 per share | |
| Kevin Chung | Chief Medical Officer | Purchase of securities on an exchange or from another person at price $ 0.48 per share. | 30 May 2023 | 2,300 | 66,975 | - | 0.5 | 1,093 | Common Stock, par value $0.0001 per share |
| Kevin Chung | Chief Medical Officer | Purchase of securities on an exchange or from another person at price $ 0.47 per share. | 30 May 2023 | 1,150 | 68,125 | - | 0.5 | 546 | Common Stock, par value $0.0001 per share |
| Kevin Chung | Chief Medical Officer | Purchase of securities on an exchange or from another person at price $ 0.47 per share. | 30 May 2023 | 5,093 | 60,675 | - | 0.5 | 2,394 | Common Stock, par value $0.0001 per share |
| Kevin Chung | Chief Medical Officer | Purchase of securities on an exchange or from another person at price $ 0.48 per share. | 30 May 2023 | 4,000 | 64,675 | - | 0.5 | 1,920 | Common Stock, par value $0.0001 per share |
| Richard D. Russell | Director | Purchase of securities on an exchange or from another person at price $ 0.50 per share. | 23 May 2023 | 20,000 | 27,978 | - | 0.5 | 10,000 | Common Stock, par value $0.0001 per share |
| Kevin Chung | Chief Medical Officer | Purchase of securities on an exchange or from another person at price $ 0.70 per share. | 18 May 2023 | 7,500 | 55,582 | - | 0.7 | 5,249 | Common Stock, par value $0.0001 per share |
| Rick Barnett | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Apr 2023 | 11,967 | 11,967 | - | - | Stock Option (Right to Buy) | |
| Allan Collins | Director | 06 Apr 2023 | 7,978 | 16,400 | - | 0 | Common Stock, par value $0.0001 per share | ||
| Kenneth Van Heel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Apr 2023 | 7,978 | 16,400 | - | 0 | Common Stock, par value $0.0001 per share | |
| Kenneth Van Heel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Apr 2023 | 11,967 | 11,967 | - | - | Stock Option (Right to Buy) | |
| Allan Collins | Director | 06 Apr 2023 | 11,967 | 11,967 | - | - | Stock Option (Right to Buy) | ||
| Andres Lobo | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Apr 2023 | 11,967 | 11,967 | - | - | Stock Option (Right to Buy) | |
| Andres Lobo | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Apr 2023 | 7,978 | 7,978 | - | 0 | Common Stock, par value $0.0001 per share | |
| Rick Barnett | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Apr 2023 | 7,978 | 16,400 | - | 0 | Common Stock, par value $0.0001 per share | |
| Richard D. Russell | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Apr 2023 | 11,967 | 11,967 | - | - | Stock Option (Right to Buy) | |
| Caryl Baron | Interim CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Apr 2023 | 11,080 | 53,192 | - | 0 | Common Stock, par value $0.0001 per share | |
| Caryl Baron | Interim CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Apr 2023 | 16,621 | 16,621 | - | - | Stock Option (Right to Buy) | |
| Eric Schlorff | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Apr 2023 | 99,724 | 99,724 | - | - | Stock Option (Right to Buy) | |
| Eric Schlorff | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Apr 2023 | 66,483 | 265,013 | - | 0 | Common Stock, par value $0.0001 per share | |
| Bruce M. Rodgers | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Apr 2023 | 7,978 | 7,978 | - | 0 | Common Stock, par value $0.0001 per share | |
| Bruce M. Rodgers | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Apr 2023 | 11,967 | 11,967 | - | - | Stock Option (Right to Buy) | |
| Richard D. Russell | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Apr 2023 | 7,978 | 7,978 | - | 0 | Common Stock, par value $0.0001 per share | |
| Kevin Chung | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Apr 2023 | 44,322 | 48,082 | - | 0 | Common Stock, par value $0.0001 per share | |
| Kevin Chung | Chief Medical Officer | Purchase of securities on an exchange or from another person at price $ 1.85 per share. | 05 Apr 2023 | 3,760 | 3,760 | - | 1.9 | 6,956 | Common Stock, par value $0.0001 per share |
| Kevin Chung | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Apr 2023 | 66,483 | 66,483 | - | - | Stock Option (Right to Buy) | |
| Kenneth Van Heel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Oct 2022 | 8,422 | 8,422 | - | 0 | Common Stock, par value $0.0001 per share | |
| Allan Collins | Director | 28 Oct 2022 | 24,483 | 24,483 | - | - | Stock Option (Right to Buy) | ||
| Allan Collins | Director | 28 Oct 2022 | 8,422 | 8,422 | - | 0 | Common Stock, par value $0.0001 per share | ||
| Rick Barnett | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Oct 2022 | 8,422 | 8,422 | - | 0 | Common Stock, par value $0.0001 per share | |
| Rick Barnett | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Oct 2022 | 24,483 | 24,483 | - | - | Stock Option (Right to Buy) | |
| Caryl Baron | Interim CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Oct 2022 | 19,685 | 19,685 | - | - | Stock Option (Right to Buy) | |
| Caryl Baron | Interim CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Oct 2022 | 4,796 | 4,796 | - | - | Stock Option (Right to Buy) | |
| Caryl Baron | Interim CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Oct 2022 | 42,112 | 42,112 | - | 0 | Common Stock, par value $0.0001 per share | |
| Eric Schlorff | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Oct 2022 | 17,986 | 17,986 | - | - | Stock Option (Right to Buy) | |
| Eric Schlorff | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Oct 2022 | 198,530 | 198,530 | - | 0 | Common Stock, par value $0.0001 per share | |
| Eric Schlorff | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Oct 2022 | 83,985 | 83,985 | - | - | Stock Option (Right to Buy) | |
| Kenneth Van Heel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Oct 2022 | 24,483 | 24,483 | - | - | Stock Option (Right to Buy) |